Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-β and inflammatory reaction

Journal of Submicroscopic Cytology and Pathology

Volumn 31, Issue 4, 1999, Pages 571-579

  Thomas, Tom ^a,b   Rhodin, J A G ^a   Sutton, E T ^a   Bryant, M W ^a   Price, J M ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Woodlands Med and Research Center   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Arteriolar endothelial cells; Estrogen; Inflammatory response; Intravital microscopy

Indexed keywords

AMYLOID BETA PROTEIN; CONJUGATED ESTROGEN; ESTROGEN;

AGED; ALZHEIMER DISEASE; ANIMAL; ARTICLE; BLOOD VESSEL; BRAIN CIRCULATION; CORONARY ARTERY DISEASE; DISEASE MODEL; DRUG EFFECT; ELECTRON MICROSCOPY; ESTROGEN THERAPY; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BLOOD VESSELS; CEREBROVASCULAR CIRCULATION; CORONARY DISEASE; DISEASE MODELS, ANIMAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; INFLAMMATION; MALE; MICROSCOPY, ELECTRON; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033202738     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. DIAZ-GONZALES F. and SANCHEZ-MADRID F., 1998. Inhibition of leukocyte adhesion: An alternative mechanism of action for anti-inflammatory drugs. Immunol. Today, 19, 169-17
2. EGLITIS M.A. and MEZEY E., 1997. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA, 94, 4080-4085.
3. FALLOWFIELD L., 1996. Protection against Alzheimer's disease. Lancet, 348, 420-421.
4. GEULA C., WU C.-K., SAROFF D., LORENZO A., YUAN M. and YANKNER B.A., 1998. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med., 4, 827-831.
5. GRADY D., RUBIN S.M., PETITTI D.B., FOX C.S., BLACK D., ETTINGER B., ERNSTER V.L. and CUMMINGS S.R., 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med., 117, 1016-1037.
6. HENDERSON V.W., PAGANINI-HILL A., EMANUEL C.K., DUNN M.E. and BUCKWALTER J.G., 1994. Estrogen replacement therapy in older women: Comparisons between AD cases and non-demented control subjects. Arch. Neurol., 51, 896-900.
7. HULLEY S., GRADY D., BUSH T., FURBERG C., HERRINGTON D., RIGGS B. and VITTINGHOFF E., 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J. Am. Med. Assn., 280, 605-613.
8. KAWAS C., RESNIK S., MORRISON A., BROOKMEYER R., CORRADA M., ZONDERMAN A., BACAL C., DONNELL-LINGLE D. and METTER E., 1997. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore longitudinal study of aging. Neurology, 48, 1517-1521.
9. MAAT-SCHIEMAN M.L., VAN DUINEN S.G., ROZEMULLER A.J., HAAN J. and ROOS R.A., 1997. Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer's disease. Neuropathol. Exp. Neurol., 56, 273-284.
10. MCGEER P.L., SCHULZER M. and MCGEER E.G., 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology, 47, 425-432.
11. PASIMETTI G.M., 1996. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system. Neurobiol. Aging, 17, 707-716.
12. PRICE J.M., SUTTON E.T., HELLERMAN A. and THOMAS T., 1997. β-amyloid induces cerebrovascular endothelial dysfunction in the rat brain. Neurol. Res., 19, 534-538.
13. RIPICH D.N., PETRILL S.A., WHITEHOUSE and ZIOL E.W., 1995. Gender differences in language of AD patients: A longitudinal study. Neurology, 45, 299-302.
14. RUBANYI G.M., 1993. The role of endothelium in cardiovascular homeostasis and disease. Cardiovasc. Pharmacol., 22 (suppl. 4), S1-S14.
15. SELKOE D.J., 1994. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Ann. Rev. Cell. Biol., 10, 373-403.
16. TANG M.-X., JACOBS D., STERN Y., MARDER K., SCHOFIELD P., GURLAND B. and ANDREWS H., 1996. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429-432.
17. THOMAS T., THOMAS G., MCLENDON C., SUTTON T. and MULLAN M., 1996. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature, 380, 168-171.
18. THOMAS T., MCLENDON C., SUTTON E.T. and THOMAS G., 1997a. Cerebro-vascular endothelial dysfunction mediated by β-amyloid. NeuroReport, 8, 1387-1391.
19. THOMAS T., SUTTON E.T., BRYANT M.W. and RHODIN J.A., 1997b. In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid. J. Submicrosc. Cytol. Pathol., 29, 293-304.
20. THOMAS T., MCLENDON C., TUGERTIMUR A. and THOMAS K., 1998. Amyloid β-peptides Aβ 1-40 and Aβ 1-42 induce cerebrovascular endothelial dysfunction. Alzheimer's Reports, 1, 17-24.
21. UCHIHARA T., AKIYAMA H., KONDO H. and IKEDA K., 1997. Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain. Stroke, 28, 1948-1950.
22. WENGER N.K., 1998. Postmenopausal hormone therapy: Is it useful for coronary prevention? Cardiol. Clin., 16, 17-25.
23. XU H., GOURAS G.K., GREENFIELD J.P., VINCENT B., NASLUND J., MAZZARELLI L., FRIED G., JOVANOVIC J.N., SEEGER M., RELKIN N.R., LIAO F., CHECLER F., BUXBAUM J.D., CHAIL B.T., THINAKARAN G., SISODIA S.S., WANG R., GREENGARD P. and GANDY S., 1998. Estrogen reduces neuronal generation of Alzheimer's β-amyloid peptides. Nature Med., 4, 447-451.